Literature DB >> 15207732

Mesenchymal stem cells from cryopreserved human umbilical cord blood.

Myoung Woo Lee1, Jeongeun Choi, Mal Sook Yang, Young Joon Moon, Joon Seong Park, Hugh C Kim, Young Jin Kim.   

Abstract

Umbilical cord blood (UCB) is well known to be a rich source of hematopoietic stem cells with practical and ethical advantages, but the presence of mesenchymal stem cells (MSCs) in UCB has been disputed and it remains to be validated. In this study, we examined the ability of cryopreserved UCB harvests to produce cells with characteristics of MSCs. We were able to obtain homogeneous plastic adherent cells from the mononuclear cell fractions of cryopreserved UCB using our culture conditions. These adherent cell populations exhibited fibroblast-like morphology and typical mesenchymal-like immunophenotypes (CD73+, CD105+, and CD166+, etc.). These cells presented the self-renewal capacity and the mesenchymal cell-lineage potential to form bone, fat, and cartilage. Moreover, they expressed mRNAs of multi-lineage genes including SDF-1, NeuroD, and VEGF-R1, suggesting that the obtained cells had the multi-differentiation capacity as bone marrow-derived MSCs. These results indicate that cryopreserved human UCB fractions can be used as an alternative source of MSCs for experimental and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207732     DOI: 10.1016/j.bbrc.2004.04.206

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation.

Authors:  Tatiana Taís Sibov; P Severino; L C Marti; L F Pavon; D M Oliveira; P R Tobo; A H Campos; A T Paes; E Amaro; L F Gamarra; C A Moreira-Filho
Journal:  Cytotechnology       Date:  2012-02-12       Impact factor: 2.058

2.  Differentiation of cryopreserved human umbilical cord blood-derived stromal cells into cells with an oligodendrocyte phenotype.

Authors:  Yong-Chun Luo; Hong-Tian Zhang; Hao-Yu Cheng; Zhi-Jun Yang; Yi-Wu Dai; Ru-Xiang Xu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-27       Impact factor: 2.416

3.  Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.

Authors:  Xin-Qin Kang; Wei-Jin Zang; Li-Jun Bao; Dong-Ling Li; Tu-Sheng Song; Xiao-Li Xu; Xiao-Jiang Yu
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

Review 4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

5.  Tissue Engineering with Nano-Fibrous Scaffolds.

Authors:  Laura A Smith; Xiaohua Liu; Peter X Ma
Journal:  Soft Matter       Date:  2008-01-01       Impact factor: 3.679

6.  Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix.

Authors:  B Corradetti; A Lange-Consiglio; M Barucca; F Cremonesi; D Bizzaro
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

7.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

8.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

9.  Stem cells for reprogramming: could hUMSCs be a better choice?

Authors:  Paulina Duya; Yuhong Bian; Xiaoqian Chu; Yanjun Zhang
Journal:  Cytotechnology       Date:  2012-09-12       Impact factor: 2.058

10.  Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue.

Authors:  Jun Deng; Zhong-min Zou; Tao-li Zhou; Yong-ping Su; Guo-ping Ai; Jun-ping Wang; Hui Xu; Shi-wu Dong
Journal:  Neurol Sci       Date:  2011-06-16       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.